Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Biote (BTMD) Cost of Revenue (2021 - 2025)

Biote (BTMD) has 3 years of Cost of Revenue data on record, last reported at $14.0 million in Q4 2023.

  • For Q4 2023, Cost of Revenue fell 9.2% year-over-year to $14.0 million; the TTM value through Dec 2023 reached $57.9 million, up 37.31%, while the annual FY2024 figure was $58.1 million, 0.44% changed from the prior year.
  • Cost of Revenue reached $14.0 million in Q4 2023 per BTMD's latest filing, down from $14.2 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $45.6 million in Q4 2021 and bottomed at $1.1 million in Q2 2022.
  • Average Cost of Revenue over 3 years is $14.4 million, with a median of $13.9 million recorded in 2023.
  • Peak YoY movement for Cost of Revenue: plummeted 90.43% in 2022, then surged 1320.83% in 2023.
  • A 3-year view of Cost of Revenue shows it stood at $45.6 million in 2021, then tumbled by 66.17% to $15.4 million in 2022, then fell by 9.2% to $14.0 million in 2023.
  • Per Business Quant database, its latest 3 readings for Cost of Revenue were $14.0 million in Q4 2023, $14.2 million in Q3 2023, and $15.8 million in Q2 2023.